Literature DB >> 18854408

Does controlled ovarian stimulation prior to chemotherapy increase primordial follicle loss and diminish ovarian reserve? An animal study.

E Maman1, K Prokopis, J Levron, A Carmely, J Dor, D Meirow.   

Abstract

BACKGROUND: Storage of embryos for fertility preservation before chemotherapy is widely practiced. For multiple oocyte collection, the ovaries are hyperstimulated with gonadotrophins that significantly alter ovarian physiology. The effects of ovarian stimulation prior to chemotherapy on future ovarian reserve were investigated in an animal model.
METHODS: Cyclophosphamide (Cy) in doses of 0, 50 or 100 mg/kg was administered to 38 adult mice (control, unstimulated). A second group of 12 mice were superovulated with equine chorionic gonadotrophin (eCG, 10 IU on Day 0) before Cy administration; hCG (10 IU) was administered (Day 2) followed by 0, 50 or 100 mg/kg Cy (Day 4). In both groups ovaries were removed, serially sectioned (7-day post-Cy), primordial follicles were counted and differences between groups evaluated.
RESULTS: Follicle number dropped from 469 +/- 24 (mean +/- SE) to 307 +/- 27 and 234 +/- 19 with 50 or 100 mg/kg Cy, respectively (P < 0.0001). In the eCG pretreated group, follicle count dropped from 480 +/- 31 to 345 +/- 16 and 211 +/- 26 when 50 or 100 mg/kg Cy were administered (P < 0.0001). There were no significant differences in follicle count between the pretreated eCG group and controls for each chemotherapy dose.
CONCLUSIONS: This animal study indicates that ovarian stimulation before administration of Cy does not adversely affect ovarian reserve post-treatment. These results provide support for the safety of fertility preservation using ovarian stimulation and IVF-embryo cryopreservation procedures prior to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854408     DOI: 10.1093/humrep/den337

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  5 in total

1.  Retrovirus-mediated multidrug resistance gene (MDR1) overexpression inhibits chemotherapy-induced toxicity of granulosa cells.

Authors:  Sana M Salih
Journal:  Fertil Steril       Date:  2011-02-12       Impact factor: 7.329

2.  Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location.

Authors:  Micah J Hill; Janelle C Cooper; Gary Levy; Connie Alford; Kevin S Richter; Alan H DeCherney; Charles L Katz; Eric D Levens; Erin F Wolff
Journal:  Fertil Steril       Date:  2013-11-20       Impact factor: 7.329

Review 3.  Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT.

Authors:  Michael von Wolff; Markus Montag; Ralf Dittrich; Dominik Denschlag; Frank Nawroth; Barbara Lawrenz
Journal:  Arch Gynecol Obstet       Date:  2011-03-24       Impact factor: 2.344

Review 4.  Melatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy.

Authors:  Hoon Jang; Kwonho Hong; Youngsok Choi
Journal:  Int J Mol Sci       Date:  2017-06-07       Impact factor: 5.923

5.  Effects of cyclophosphamide administration on the in vitro fertilization of mice.

Authors:  Megumi Koike; Akiko Kanda; Kyoko Kido; Kaori Goto; Yoko Kumasako; Miyuki Nagaki; Eiko Otsu; Yasuyuki Araki; Yasuhisa Araki; Fumiko Kawabe; Yufuko Kai; Takafumi Utsunomiya
Journal:  Reprod Med Biol       Date:  2018-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.